In this randomized controlled trial, adjuvant therapy with durvalumab led to improved overall and progression-free survival ...

CURE® spoke with a lung cancer treatment expert about study findings showing survival benefits with the addition of ...

NewsVoir Mumbai Maharashtra [India]2 Lung cancer remains one of the most prevalent and deadly cancers globally with approximately 22 million new cases diagnosed annually contributing to 18 of all canc ...

A $2 million donation creates The Barbara C. Killian Thoracic Oncology Fund to support patients who battle cancer like Mrs.

Application error: a client-side exception has occurred (see the browser console for more information).

Researchers have unlocked a key in a person's immune response that could halt the spread of cancer the body cannot see.

Keytruda’s sales are gaining from rapid uptake across earlier-stage indications, mainly early-stage non-small cell lung ...

Today marks two years since WTOP’s Neal Augenstein was diagnosed with stage 4 lung cancer. He reflects on where he’s been in his journey, and what comes next.

Panelist discusses how the future treatment landscape for EGFR-mutant advanced non–small cell lung cancer is evolving to address current unmet needs and offers clinical pearls to community oncologists ...

non-small cell lung cancer, and gynecological cancers. Its lead product, Amtagvi, is a TIL therapy approved for metastatic ...

therapeutics in clinical programs targeting indications such as RAS-mutated metastatic colorectal cancer (mCRC), as well as in ongoing and planned investigator-initiated trials in metastatic ...